CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia
{{output}}
Acute myeloid leukemia (AML) is the most common form of acute leukemia with dismal long-term prognosis with age. The most aggressive subtype of AML is MLL-AML that is characterized by translocations of the mixed-lineage leukemia gene (MLL) and resistance to co... ...